Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
75%(3 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_2
2
50%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 22 (50.0%)
N/A1 (25.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Preoperative Gabapentin for Post-tonsillectomy Pain in Children

NCT01707420
completedphase_2

Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis

NCT01399047
completedphase_1

Rivastigmine Study in Adolescents With Down Syndrome

NCT01084135
completedphase_2

Vitamin/Mineral Supplement for Children and Adults With Autism

NCT01225198

Clinical Trials (4)

Showing 4 of 4 trials
NCT01707420Not Applicable

Preoperative Gabapentin for Post-tonsillectomy Pain in Children

Completed
NCT01399047Phase 2

Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis

Completed
NCT01084135Phase 1

Rivastigmine Study in Adolescents With Down Syndrome

Completed
NCT01225198Phase 2

Vitamin/Mineral Supplement for Children and Adults With Autism

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4